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doi:10.1016/j.jfma.2010.12.002Background/Purpose: Endoscopic submucosal dissection (ESD) is an advanced endoscopic
procedure to resect early gastrointestinal neoplasm. It is technically more difficult and risky
when used to treat early esophageal tumors. We report our experiences related to performing
ESD for early esophageal neoplasia. The efficacy, complications, and outcome were also
analyzed.
Methods: From December 2007 to April 2010, 22 patients with documented early esophageal
neoplasm underwent ESD. All patients completed a meticulous endoscopic examination using
conventional endoscopy followed by narrow-band imaging. Lugol’s staining was performed to
identify themarginof the suspicious lesion. Insulation-tippeddiathermic knife2wasused forESD.
Results: A total of 26 neoplastic lesions (including 13 tumorswith high-grade dysplasia, 12 tumors
with squamous cell carcinoma, and one tumor with adenocarcinoma) in 22 patients were
enrolled. All patients were men. The mean age was 47.6  8.6 years (range, 30e68 years). The
mean size of tumors was 33.7  21.7 mm (range, 8e80 mm). ESD was performed for 24 lesions
in 20 patients. The mean size of resected specimens was 43.1  19.2 mm (range, 15e90 mm).
The mean operation time was 92.7  69 minutes (range, 30e310 minutes). There were three
ESD-related complications, including one with delayed bleeding, one with subcutaneous emphy-
sema, and one with perforation. Two patients received additional operations after ESD due to
deep submucosal invasion by cancer. Three lesions in two patients (12.5%) developed post-ESD
esophageal stricture that needed repeated endoscopic bougination. There was no procedure-
related mortality. No local recurrence was found during the follow-up period.of Internal Medicine, E-Da Hospital, I-Shou University, 1, E-Da Road, Jiau-shu Tsuen, Yan-chau Shiang,
.tw (J.-T. Lin).
ight ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
Submucosal dissection for esophageal neoplasia 133Conclusion: ESD is a promising local curative treatment option for early esophageal neoplasia in
Taiwan. However, this procedure may result in complications that are worth noting, especially
post-ESD esophageal stricture. Education regarding this procedure and more hands-on training
will facilitate endoscopists to improve the outcomes of patients undergoing this procedure.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
For early esophageal neoplasia, endoscopic mucosal
resection (EMR) has been shown to be a safer alternative,
with long-term survival outcomes similar to those achieved
with surgery.1e4 However, EMR is hampered by some tech-
nical limitations. Less than one-half of the patients treated
with EMR have been reported to have an en bloc resection,
and, in particular, en bloc resection of lesions larger than
20 mm is extremely difficult.1e6 Moreover, post-EMR
recurrence or metachronous carcinoma has been reported
in as many as 26% of the cases.1e9
Using a new endoscopic knife, endoscopic submucosal
dissection (ESD) was first developed for resection of early
gastric cancer by Hosokawa and colleagues.10 ESD enables
the endoscopist to achieve an en bloc resection regardless of
the tumor size. Despite technical difficulties, ESD has been
shown to be an effective and relatively safe treatment for
the squamous cell carcinoma of the esophagus.5,11,12
Esophageal cancer represents one of the most common
malignancies worldwide and is currently the ninth leading
cause of cancer death in Taiwan.13 Esophageal squamous
cell carcinoma is a highly aggressive form of this malignancy
with a 5-year survival rate of less than 20%.14 In Taiwan,
only one report involved endoscopic mucosal resection of
early esophageal neoplasia.15 Most preliminary applications
of ESD have been performed exclusively in Japan; this is
presumably because of the higher numbers of patients
diagnosed with early esophageal cancer during screening
endoscopy for asymptomatic patients.16
To further enhance clinician’s understanding of the
usefulness of this procedure and its related risks, we report
our experiences in performing ESD for early esophageal
neoplasia at E-Da hospital. The efficacy, complications, and
outcome of ESD were also analyzed.Materials and methods
From December 2007 to April 2010, patients at high risk of
esophageal neoplasia (including cases of head and neck
cancers and betel nut users) received meticulous screening
of the esophagus with white-light endoscopy followed by
magnifying endoscopy with narrow-band-imaging (NBI)
system regardless of symptoms. When a well-demarcated
brownish area with scattered brown spots, themicrovascular
pattern, was detected by the NBI system, further endoscopic
magnification was employed to classify the intra-epithelial
papillary capillary loop (IPCL) pattern (types IeV) according
to the method proposed by Inoue and colleagues.17e19 For
any lesion suspected to be neoplastic, Lugol staining was
performed. All suspected lesions detected were biopsiedfor histological evaluation by a senior pathologist (Dr. J. C.
Hwang). The final histopathologic diagnosis, which was
based on the World Health Organization international
histological classification,20 was either non-neoplasia
(including inflammation, epithelial hyperplasia, and ulcer)
or neoplasia (including low-grade dysplasia, high-grade
dysplasia, and carcinoma). The diagnosis of “early” esoph-
ageal neoplasia included low-grade dysplasia, high-grade
dysplasia, and carcinoma limited in the mucosa. Tumor
location was classified as being in the upper, middle, lower
third of the esophagus, or esophageal-cardiac junction.
Endoscopic ultrasonography (EUS) was performed for inva-
sion depth and regional lymph node. All patients underwent
computed tomography (CT) of the chest and abdomen to
confirm that there was no distant metastasis. Positron
emission tomography (PET) was arranged in patients with
biopsy-proved carcinoma or those with dysplasia but ques-
tionable regional lymph node detected by EUS or CT. Any
patient with a suspicious submucosal-invasion lesion, or with
any possibility of regional lymph node or distal metastasis by
image study (EUS, CT, or PET) would not undergo ESD.
Benefits and risks of ESD were informed to all patients and
accompanied families. Informed consent was obtained for all
of the patients.
ESD preparation and equipment
During the study period, 26 documented early esophageal
neoplasia in 22 patients were enrolled for possible ESD at E-
Da hospital in South Taiwan. A complete medical history
was obtained before ESD, which included demographic and
clinical data. Alcohol drinkers, betel nut chewers, and
cigarette smokers were defined as those consuming any
alcoholic beverage during the week, those who had chewed
more than seven betel nuts per week, and those who
smoked more than 10 cigarettes per week for at least 6
months, respectively.21 Dyspeptic symptoms were defined
as nausea, vomiting, epigastric pain, or sensation of full-
ness. Reflux symptoms were defined as acid regurgitation or
a retro-sternal burning sensation. Esophageal symptoms
were defined as dysphagia or odynophagia. Patients
underwent a fasting period in excess of 8 hours before
receiving ESD. Endotracheal intubation and general anal-
gesia were required and were performed by an anesthetist
in one of our operating rooms. Patients were then placed in
the left lateral decubitus position to receive ESD, which
was conducted with a magnifying endoscope (GIF-H260Z,
Olympus Optical Co., Ltd., Tokyo, Japan). The EVIS LUCERA
SPECTRUM Video Imaging System (Olympus Optical Systems
Co., Ltd., Tokyo, Japan) was employed for NBI. A distal
attachment (D-201-11802; Olympus) was attached to the
tip of the endoscope to obtain a constant endoscopic view
134 C.-T. Lee et al.and to create tension on the connective tissue for the
submucosal dissection.
ESD procedure
Prior to ESD, Lugol spraying was performed to demarcate
the margin of the lesion. Several spots were marked at
2e3 mm outside the margin of the esophageal neoplasia
by using argon plasma coagulation (ERBE, Tuebingen, Ger-
many) to ensure a cancer-free margin. Next, using a 23-
gauge disposable injector, 3e5 ml glycerol solution plus
indigo-carmine with 0.0025% epinephrine was injected into
the submucosa to lift the lesion. A circumferential incision
was made initially, followed by submucosal dissection with
the IT-knife 2 (KD-610L; Olympus Co. Ltd., Tokyo, Japan). To
control bleeding, hemostatic forceps (FD-410LR; Olympus)
were used in a soft coagulation mode (60-W output). This is
shown in Fig. 1.
After resection, all patients were treated with oral
sucralfate and an intravenously administered proton pump
inhibitor (pantoprazole 40 mg) was given simultaneously for
patients with lower esophageal lesions. The day after ESD,Figure 1 (A) Chromoendoscopy with Lugol staining revealed a 2 
ulcer after ESD; (C) a 3  3 cm resected specimen with the lesio
differentiated squamous cell carcinoma with lamina propria invas
cosal dissection.all patients received a second-look endoscopy to evaluate
the condition of the wound. If there was no evidence of
bleeding, the patient was put on a liquid diet followed by
a soft diet the following day, and were then generally dis-
charged within few days. If complications occurred, the
patient’s schedules were changed according to the indi-
vidual condition of each patient.Complications of ESD
Immediate complications included massive bleeding,
emphysema, and perforation during ESD. Latent complica-
tions included delayed bleeding and perforation after ESD.
Massive bleeding was defined as blood loss >500 ml or
a hemoglobin drop>2 g/dl. Perforation was diagnosed when
other organs, extraluminal fat, or the extraluminal space
were observed endoscopically through the muscle layer
during ESD. Mediastinal emphysema was diagnosed by the
presence of air in the mediastinal space. A postoperative
stricture was defined as a stricture that required endoscopic
treatment.2 cm Lugol-voiding area in the mid esophagus; (B) an artificial
n in en bloc fashion is shown; (D) pathology revealed a well-
ion (hematoxylin and eosin, 40). ESD Z endoscopic submu-
Table 2 Endoscopic and pathologic characteristics of
early esophageal neoplastic lesions.
Total lesions (n Z 26) a
Tumor location
Upper third esophagus 4 (15.4%)
Middle third esophagus 15 (57.7%)
Lower third esophagus 6 (32.1%)
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The resected specimens were fixed on a piece of board and
immersed in 4% formalin for the final pathologic examina-
tion. After being embedded in 100% paraffin, all specimens
were cut into 2-mm slices and stained with hematoxylin and
eosin. The tumor size, depth of invasion, lymphovascular
invasion, grade of differentiation, and resection margins
were histopathologically examined. The depth of invasion
was subclassified as intraepithelial cancer (m1), cancer
invading the lamina propria (m2), and cancer invading the
muscularis mucosae (m3). In patients in whom the cancer
was invading the superficial portion of the submucosa, the
invading depth was defined as sm-minor. On the other
hand, if the cancer was invading the deep portion of the
submucosa, the invading depth was defined as sm-massive.
One-piece resection was defined as en bloc resection. R0
resection was considered to have a tumor-free margin when
vertical and horizontal margins were free of tumor cells.
Follow-up
Post-ESD treatment (surgery or chemoradiation) was
considered for patients with an incomplete resected margin
at histology. In those patients in whom ESD was considered
the definitive treatment, they received an upper GI
endoscopy at follow-up 1 month after ESD and then again at
regular followed-up every 3 months during the first year
after ESD. After the first year, patients received this
examination every 6 months and then annually thereafter.
Lugol spraying was applied during follow-up and endoscopic
biopsies were taken from any Lugol-voiding areas to iden-
tify any residual or recurrent neoplasia.Table 1 Demographic characteristics of 22 patients with
early esophageal neoplastic lesions.
Total patients (n Z 22) a
Age, mean  SD (yr) 47.6  8.6 (30e68)
Sex
Men 22 (100%)
Women 0 (0%)
Smoking 22 (100%)
Alcohol drinker 22 (100%)
Betal nut chewing 16 (72.7%)
History of head and neck cancer 16 (72.7%)
Tongue cancer 2
Hypopharyngeal cancer 6
Oropharyngeal cancer 5
Tonsil cancer 3
Asymptomatic 11 (50.0%)
Dyspeptic symptom 6 (27.3%)
GERD symptom 3 (13.6%)
Esophageal symptom 2 (9.1%)
Coexistent erosive esophagitis 7 (31.8%)
Coexistent Barrett’s esophagus 2 (9.1%)
GERD Z gastroesophageal reflux disease; SD Z standard
deviation.
a 26 lesions detected in 22 patients.Results
Characteristics of the study population
A total of 26 early-stage esophageal neoplasia in 22 patients
[including 13 (50%) lesions with high-grade dysplasia, 12
(46.2%) with squamous cell carcinoma, and 1 (3.8%) with
adenocarcinoma] were detected during this period. The
demographic characteristics of these patients are pre-
sented in Table 1. All of the patients were men. The mean
age was 47.6  8.6 years (range, 30e68 years). Smoking
(100%), alcohol drinking (100%), and betel nut chewing
(72.7%) were prevalent social behaviors. A total of 16
(72.7%) patients had history of head and neck cancers. One-
half of the patients were asymptomatic, six (27.3%)
patients had dyspeptic symptoms, three (13.6%) patients
had esophageal reflux symptoms, and only two (9.1%)
patients had esophageal symptoms.
Endoscopic and pathologic characteristics
The endoscopic and pathological characteristics of these
lesions are summarized in Table 2. The mean size of tumors
was 33.7  21.7 mm (range, 8e80 mm). Overall, fourEsophagocardial junction 1 (3.8%)
Tumor morphology
Type-0 IIa 3 (11.5%)
Type-0 IIb 12 (46.2%)
Type-0 IIc 11 (42.3%)
Tumor size in mm,
mean  SD (range)
33.7  21.7 (8e80)
Circumferential extension of tumor
<1/2 14 (53.8%)
<3/4 10 (38.5%)
3/4 2 (7.7%)
Final pathology
High-grade dysplasia 13 (50.0%)
Squamous cell carcinoma 12 (46.2%)
Adenocarcinoma 1 (3.8%)
Depth of tumor invasion
Mucosa 22
m1 18 (69.2%)
m2 2 (7.7%)
m3 2 (7.7%)
Submucosa 4
sm-minor 2 (7.7%)
sm-massive 2 (7.7%)
SD Z standard deviation.
a 26 lesions detected in 22 patients.
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the middle third, six (32.1%) in the lower third, and one
(3.8%) in the esophagocardial junction. The macroscopic
type was IIa in three (11.5%) lesions, IIb in 12 (46.2%), and
IIc in the remaining 11 (42.3%) lesions. Fourteen (53.8%)
lesions extended less than one-half of the circumference of
the esophageal lumen, but two (7.7%) extended more than
three-fourths of the circumference.
Regarding depth of invasion, intraepithelial cancer (m1)
was diagnosed in 18 (69.2%) lesions, cancer invading the
lamina propria mucosae (m2) in two (7.7%), cancer invading
the muscularis mucosae (m3) in two (7.7%), and cancer
invading superficial submucosa (sm-minor) in two (7.7%),
whereas deep submucosal invasion (sm-massive) was re-
ported in the remaining two (7.7%) patients.
Endoscopic submucosal dissection
ESD was performed for 24 lesions in 20 patients, except for
two patients with bleeding tendency. The mean procedure
time was 92.7  69 minutes (range, 30e310 minutes). The
mean size of resected specimens was 43.1  19.2 mm
(range, 15e90 mm). At endoscopy, en bloc resection of theFigure 2 (A) Chromoendoscopy with Lugol staining revealed a II
circumference of the esophageal lumen; (B) postoperative stricture
for esophageal stricture; (D) stricture resolved after balloon dilatilesion was successful in 23 (95.8%) lesions. Resection-free
margins (R0 resection) were achieved in 21 (87.5%) lesions.
Only two lesions presented with incomplete resection due
to deep submucosal invasion, and ESD was stopped in one
patient due to severe subcutaneous emphysema during the
procedure.
There were three (12.5%) ESD-related complications:
one with delayed bleeding, one with perforation during
ESD, and one with mediastinal/subcutaneous emphysema
during the procedure. Regarding patients with ESD-related
complications, one with delayed bleeding received
successful endoscopic hemostasis, one with mediastinal/
subcutaneous emphysema received supportive treatment,
and the remaining patient with perforation during ESD
received urgent operation due to unstable vital signs. All
three patients were discharged without sequela. Additional
esophagectomies were performed in two patients due to
deep submucosal invasion by the cancer. Three lesions
(12.5%) in two patients developed post-ESD esophageal
stricture who needed repeated endoscopic bougination
(Fig. 2). There was no procedure-related mortality. No local
recurrence was found during the follow-up period (mean,
11.5 months). These results are shown in Table 3.b Lugol-voiding area with extension more than one-half of the
developed 3 months after ESD; (C) balloon dilation performed
on. ESD Z endoscopic submucosal dissection.
Table 3 ESD for 24 esophageal neoplastic lesions: Proce-
dures and complications.
Total lesions in
20 patients
Procedure time in min, mean  SD
(range)
92.7  69.0
(30e310)
Diameter of resected specimen in
mm, mean  SD (range)
43.1  19.2
(15e90)
En-bloc resection 23 lesions (95.8%)
R0 resection 21 lesions (87.5%)
ESD-related complications 3 (12.5%)
Massive bleeding during ESD 0
Delayed bleeding 1
Perforation during ESD 1
Subcutaneous emphysema 1
Blood transfusion 0 (0%)
Emergent surgery 1 (4.2%)
Additional surgery 2 (8.3%) a
Esophageal stricture need
Bougination after ESD
3 (12.5%)
Local recurrence 0 (0%) b
Mortality 0 (0%) b
ESD Z endoscopic submucosal dissection; SD Z standard
deviation.
a Two with confirmed deep submucosal invasion.
b Mean follow-up period was 11.5 months (range, 0e28
months).
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ESD is increasingly gaining acceptance and is currently the
treatment of choice for superficial esophageal neoplasia in
Japan.5,11,12 However, most of these preliminary applica-
tions of ESD have been exclusively performed in Japan. Our
study shows that ESD is also a greatly effective, technically
feasible, and relatively safe treatment for selected early
esophageal neoplasia in Taiwan. The 87.5% rate of en bloc
R0 resection of our study is in-line with the rates of 78%e
93% reported by previous Japanese series.5,11,12 Similarly,
the 12.5% major complication rate is also comparable with
the rates of the 13%e22% range extrapolated from the
Japanese studies.5,11,12
When dealing with large lesions, ESD allows en bloc
resection in the majority of the patients and represents
a substantial improvement compared with standard EMR, in
which en bloc resection of neoplasia 20 mm or larger was
feasible in only 4%e43% of the cases.1e4,6e9 In this study,
the mean size of the tumors was 33.7 mm in diameter and
the mean size of resected specimens obtained was 43.1 mm
in diameter. The higher efficacy of ESD compared with that
of EMR is also confirmed by the net difference of local
recurrence rates. Post-EMR local recurrence rate has been
consistently shown to be as high as 26%.1e4,6e9,11 On the
other hand, only 0%e3% rates of local recurrence were
reported with a R0 ESD in previous studies.5,11,12 In our
study, there was no local recurrence during the follow-up
period.
Esophageal cancer is highly aggressive with a low survival
rate worldwide.13,14 This disappointingly low survival ratecan be attributed, at least in part, to ineffective screening
tools and guidelines such that most patients have late stage
or unresectable diseases at presentation. For these reasons,
we have conducted a prospective screening project by using
NBI followed by high magnification in patients with head and
neck cancers, and betel nut users since April 2008. In this
study, the majority (72.7%) of patients had a history of head
and neck cancer and one-half involved high-grade dysplasia
of the esophagus. Most patients were diagnosed with early-
stage esophageal neoplasia after screening. In fact, our
previous work had demonstrated that NBI followed by high
magnification significantly increases the accuracy of detec-
tion of esophageal neoplasia, especially at an early stage
of the disease22 and patients with alcohol consumption,
oropharynx or hypopharynx cancer were associated with
the development of synchronous esophageal neoplasia.21
This strongly implicated routine screening of esophageal
neoplasia is beneficial and mandatory for such high-risks
patients.
From a technical point of view, ESD appears to be
a demanding procedure, especially for the esophagus. The
esophageal wall is thinner than that of the stomach. It will
move with respiratory motion and heart beat, which will
interfere adequate examination and therapeutics. Moreover,
the esophageal lumen is narrow, precluding knife maneu-
verability and endoscope retroflexion. For these reasons,
esophageal ESD seemed to be a more time-consuming and
risky procedure. Besides, esophageal ESD seems to be asso-
ciated with a relatively high risk of major complications,
such as emphysema, stricture, and perforation. Most series
reported a 4%e7% rate of perforation during ESD,11,12,23
which was similar to our result. Although perforation can
be temporarily clipped by hemoclips, our patient with
perforation developed unstable vital signs during the
procedure this resulted in an urgent operation. Fortunately,
there was no sequela after operation.
In a recent study from Japan, up to 31% patient devel-
oped pneumomediastinum after ESD by chest CT scan.24 The
authors mentioned that endoscopic muscle exposure during
ESD is a significant risk factor and all patients recovered well
after conservative treatment without any clinically signifi-
cant complications. There was one patient with severe
subcutaneous emphysema resulting postponed ESD in our
series. He recovered well under supportive treatment.
Bleeding during ESD is inevitable and can bemanagedwith
coagulation forceps and hemoclipping. Delayed bleeding
may occur, especially in patients with early gastric cancer
after ESD.25 A recent, retrospective study concluded that
a second-look endoscopy after gastric ESD may contribute
little to the prevention of delayed bleeding.25 There was no
solid evidence supporting the role of a second-look endos-
copy after esophageal ESD yet. Since limited experience, we
performed a second-look endoscopy for all patients after
ESD. One patient suffered delayed bleeding and endoscopic
hemostasis was performed successfully.
Postoperative stricture after esophageal ESD is a major
complication in long-term follow-up. Esophageal stricture
can evoke severe dysphagia, and results in a decrease in
quality of life or, occasionally, aspiration pneumonia. There
were three (12.5%) lesions that developed post-ESD stric-
ture that required endoscopic balloon dilatation in our
study. This result is within the 6.8%e18% range reported by
138 C.-T. Lee et al.previous series.11,12,23,26e28 Mizata and colleagues26 re-
ported that a lesion more than one-half of the circumfer-
ence of the esophageal lumen was a predictive factor for
esophageal stenosis after ESD. Ono and others27 also
described that a more than three-fourths of the circum-
ferential extension of tumor and tumor invasion depth more
than lamina propria (m2) were two major predictive
factors. Once esophageal stricture developed after ESD,
repeated endoscopic balloon dilatation remains the most
effective treatment method. Although there are no solid
criteria, some endoscopists perform preventive balloon
dilatation. Further large-scale studies would be needed to
address this issue.
The current study raises some concerns. First, we only
performed PET for patients with biopsy-proved carcinoma
or those with dysplasia but questionable regional lymph
node detected by EUS or CT. Previous studies had showing
PET to have a relatively low accuracy for tumor depth and
regional lymph node staging in early-stage esophageal
cancer as compared with EUS alone or EUS combined with
CT.29e31 Accordingly, EUS and CT provide better informa-
tion for regional staging in early-stage esophageal cancer.
In our series, patients were not considered to receive ESD if
regional lymph node metastasis suspected by any image
studies. Secondly, our result indicated that pre-ESD EUS
study did not preclude all patients with submucosal invasive
cancers. This finding was in concordance with other reports
that the sensitivity of EUS for tumor invasion was about 80%
for early-stage lesions.32 Since the rate of lymph node
metastasis increases in cancers with submucosal invasion,
further adjuvant therapy (such as esophagectomy, radio-
therapy, or chemotherapy) will be needed in these
patients. Finally, in spite of no local recurrence during
follow-up period in our patients, longer observation needed
to make such conclusion. Local recurrence and distal
metastasis after ESD had been demonstrated in previous
studies.23,28,33 Therefore, regular follow-up for these
patients may be warranted.
In conclusion, ESD is a promising local curative treat-
ment option for early esophageal neoplasia in Taiwan, but
it still carries the risks of perforation and bleeding.
Esophageal stricture is an important concern to be aware of
in the postoperative review of patients undergoing this
procedure. Education regarding this procedure and more
hands-on training will facilitate endoscopists to improve
the outcome of this procedure.References
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